Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tyrosine Kinase Inhibitors of BCR/ABL: Pharmacokinetic and Pharmacogenetic Study in Patients Affected by Chronic Myeloid Leukemia. Evaluation of Efficacy and Tolerability

NCT01860456 is registered in ClinicalTrials.gov with University of Pisa as lead sponsor.

NCT NCT01860456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01860456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tyrosine Kinase Inhibitors of BCR/ABL: Pharmacokinetic and Pharmacogenetic Study in Patients Affected by Chronic Myeloid Leukemia. Evaluation of Efficacy and Tolerability
Lead sponsor
University of Pisa
Phase
Observational
Overall status
Completed
Start date
May 31, 2013
Completion date
December 31, 2024
Enrollment
412 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia